Home > Products > CA72-4 & CD3
> Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (scIgG)
Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (scIgG) (CAT#: SCIGG-027)
Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CA72-4 and anti-CD3 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Gastrointestinal cancer; Ovarian cancer; Colon cancer; Gastric cancer; Breast cancer; Adenocarcinomas therapy.
There are currently no customer reviews or questions for Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (scIgG) (SCIGG-027). Click the button below to contact us or submit your feedback about this product.